Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02973633Phase 1Recruiting
Phase 1, open-label trial (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Myofiber Helix Angle at 12 months. Started Jun 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02973633.